Views | |
---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 185 |
April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | |
---|---|---|---|---|---|---|---|
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 8 | 6 | 2 | 6 | 22 | 12 | 0 |
Views | |
---|---|
2021_Correll_etal.pdf | 7452 |